Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases
Clinical trial NCT07674693 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07674693
- Sponsor
- NYU Langone Health
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.